Antitumor T Cell Responses in Patients With Bladder Cancer
NCT06334406 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2024-03-28
Summary
The main objective of this study is to evaluate the induction of Th1 anti-TERT responses by treatments in patients with bladder tumor.
Conditions
Interventions
- OTHER
-
Biological samples
Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort. Tumor tissues will be collected at baseline for three patients.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-02
- Primary Completion
- 2026-04-02
- Completion
- 2026-04-02
More Related Trials
-
URO-BCG-4 : Bladder Tumors Immunotherapy
NCT00213655 ·Status: COMPLETED
-
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
NCT03529890 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunological Response of Bladder Cancer Patients Under BCG
NCT04806178 ·Status: COMPLETED ·Phase: PHASE3
-
Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002990 ·Status: COMPLETED ·Phase: PHASE3
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of Tumor Base Size in Bladder Cancer
NCT06632340 ·Status: COMPLETED ·Phase: NA
-
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472 ·Status: RECRUITING
-
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
NCT06441110 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors
NCT05785039 ·Status: RECRUITING ·Phase: PHASE2
-
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
NCT00343356 ·Status: COMPLETED ·Phase: PHASE2
-
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
NCT05445648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
NCT03317158 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors
NCT02966691 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
NCT06632964 ·Status: RECRUITING ·Phase: PHASE1
-
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
NCT03993249 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
NCT06732531 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)
NCT03333356 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT03950362 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma
NCT04672317 ·Status: UNKNOWN ·Phase: PHASE2
-
Basal Tumours in Bladder Cancer, Response to chemoTherapy
NCT04089748 ·Status: COMPLETED
-
Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
NCT06403202 ·Status: RECRUITING
-
Biological Therapy in Treating Patients With Bladder Cancer
NCT00003779 ·Status: COMPLETED ·Phase: PHASE3
-
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
NCT06310369 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
NCT06193941 ·Status: COMPLETED